FDA's New Framework Accelerates Personalized Gene Editing for Urea Cycle Disorders Recent advancements at CHOP and Penn Medicine, utilizing the FDA's plausible mechanism framework, promise a revolutionary approach to treating urea cycle disorders with personalized gene editing.

FDA's New Framework Accelerates Personalized Gene Editing for Urea Cycle Disorders #United_States #Philadelphia #FDA #Gene_Editing #Urea_Cycle